10-K Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001144204-19-009301`
Period End Date	20181231
Filing Date	20190221
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	enzn-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 19 Cash Flow Statement 31 Stockholders Equity 9

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$6.50M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.48M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Milestone receivable	`MilestoneReceivableOnRoyaltiesCurrent`	$7.00M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Milestone receivable	`MilestoneReceivableOnRoyaltiesCurrent`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	$970.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Refundable tax credits receivable, current portion	`IncomeTaxesReceivable`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$94.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$70.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.57M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$1.94M	USD	Point-in-time
Refundable tax credits receivable, net of current portion	`IncomeTaxesReceivableNoncurrent`	$970.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total assets	`Assets`	$15.51M	USD	Point-in-time
Total assets	`Assets`	$9.51M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$225.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$439.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$143.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$78.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$368.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$517.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at December 31, 2018 and 2017	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at December 31, 2018 and 2017	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at December 31, 2018 and 2017	`CommonStockValue`	$442.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at December 31, 2018 and 2017	`CommonStockValue`	$442.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$83.65M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$83.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-74.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-69.10M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.99M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.14M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.33M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$15.51M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$9.51M	USD	Point-in-time

Income Statement 19 line items

Line Item	Tag	Value	Unit	Period
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$8.38M	USD	Annual
Royalties and milestones, net	`RoyaltyRevenueAndMilestones`	$6.92M	USD	Annual
Total revenues	`Revenues`	$8.38M	USD	Annual
Total revenues	`Revenues`	$60.00K	USD	1 Quarter
Total revenues	`Revenues`	$6.92M	USD	Annual
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.06M	USD	Annual
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.37M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.37M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.06M	USD	Annual
Operating income and income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.86M	USD	Annual
Operating income and income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.01M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$6.00K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$1.56M	USD	Annual
Net income	`NetIncomeLoss`	$5.85M	USD	Annual
Net income	`NetIncomeLoss`	$5.45M	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.12	USD	Annual
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.13	USD	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.22M	shares	Annual
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.22M	shares	Annual

Cash Flow Statement 31 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$5.85M	USD	Annual
Net income	`NetIncomeLoss`	$5.45M	USD	Annual
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	$3.36M	USD	Annual
Deferred tax provision	`DeferredIncomeTaxExpenseBenefit`	-	USD	Annual
Increase in milestone receivable	`IncreaseDecreaseInMilestonesReceivable`	$7.00M	USD	Annual
Increase in milestone receivable	`IncreaseDecreaseInMilestonesReceivable`	-	USD	Annual
Decrease in other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-24.00K	USD	Annual
Decrease in other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-176.00K	USD	Annual
Increase in refundable tax credit receivable	`IncreaseDecreaseInLongTermReceivablesCurrent`	$1.94M	USD	Annual
Increase in refundable tax credit receivable	`IncreaseDecreaseInLongTermReceivablesCurrent`	-	USD	Annual
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$214.00K	USD	Annual
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-545.00K	USD	Annual
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccruedLiabilities`	$-65.00K	USD	Annual
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccruedLiabilities`	$-27.00K	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$6.47M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-978.00K	USD	Annual
Common stock dividends	`PaymentsOfDividendsCommonStock`	-	USD	Annual
Common stock dividends	`PaymentsOfDividendsCommonStock`	$6.63M	USD	Annual
Common stock dividends	`PaymentsOfDividendsCommonStock`	$6.60M	USD	Point-in-time
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.63M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	Annual
Net decrease in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-978.00K	USD	Annual
Net decrease in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-161.00K	USD	Annual
Cash at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$6.50M	USD	Point-in-time
Cash at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$7.48M	USD	Point-in-time
Cash at end of year	`CashAndCashEquivalentsAtCarryingValue`	$7.64M	USD	Point-in-time
Cash at end of year	`CashAndCashEquivalentsAtCarryingValue`	$6.50M	USD	Point-in-time
Cash at end of year	`CashAndCashEquivalentsAtCarryingValue`	$7.48M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.33M	USD	Point-in-time
Net income	`NetIncomeLoss`	$5.85M	USD	Annual
Net income	`NetIncomeLoss`	$5.45M	USD	Annual
Common stock dividend	`DividendsCommonStockStock`	$6.63M	USD	Annual
Balance	`StockholdersEquity`	$14.99M	USD	Point-in-time
Balance	`StockholdersEquity`	$9.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.33M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.